Epidemiology of Pneumocystis jirovecii Pneumonia and (Non-)use of Prophylaxis

Epidemiology of Pneumocystis jirovecii Pneumonia and (Non-)use of Prophylaxis

Objectives:Pneumocystis jirovecii pneumonia (PCP) is an AIDS-defining illness. In patients with HIV, the benefit of PCP prophylaxis is well-defined when the CD4 T-cell count decreases below 200 cells/μL. In other immunocompromised patients, the value of PCP prophylaxis is not always as well-establis...

Full description

Bibliographic Details
Main Authors: Albert Dunbar, Alexander Schauwvlieghe, Sheruna Algoe, Jaap J. van Hellemond, Marijke Reynders, Stefaan Vandecasteele, Jerina Boelens, Pieter Depuydt, Bart Rijnders
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-05-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Pneumocystic jirovecii pneumonia
Pneumocystis jiroveci (carinii) pneumonia
prophylaxis
Trimetoprim- sulfamethoxazole
immunocompromidsed patients
Online Access:https://www.frontiersin.org/article/10.3389/fcimb.2020.00224/full

Internet

https://www.frontiersin.org/article/10.3389/fcimb.2020.00224/full

Similar Items